| Information |
|
We are able to generate a reliable list of pharmacy related sites.
|
 |
|
 |
Diovan
Diovan is a prescription drug approved to treat high blood pressure and congestive heart failure. As this eMedTV page explains, it also helps improve survival after a heart attack.
blood-pressure.e medtv.com/ diovan/ diovan.html |
 |
| |
| |
| |
|
|
Diovan, Valsartan News - Topix
... lowers blood pressure in youngsters aged 1 to 5 years who have high blood pressure ... Leading Blood Pressure Medication Diovan with Diuretic Reduces Key Sign of Artery Ageing Which ...
www.topix.com/ drug/ diovan |
|
|
|
Diovan Information from Drugs.com
Diovan (valsartan) is used to treat high blood pressure (hypertension) or heart failure. Includes Diovan side effects, interactions and indications.
www.drugs.com/ diovan.html |
|
|
|
High blood pressure medication- Diovan
High blood pressure medication- Diovan ... Diovan is the #1 prescribed medication of its type. 1 If your blood pressure is 140/90 mm Hg or higher, Diovan may help.
www.diovan.com/ info/ about/ about_diovan.jsp |
|
|
|
Diovan HCT medical facts from Drugs.com
... hydrochlorothiaz ide and valsartan is used to treat high blood pressure ... High Blood Pressure. User Reviews: 4 review(s) for Diovan HCT
www.drugs.com/ mtm/ diovan-hct.html |
|
|
|
High Blood Pressure Medication - Diovan.com
Learn about hypertension (high blood pressure), how blood pressure is measured, and what you can do to manage high blood pressure with Diovan or Diovan HCT.
www.diovan.com/ index.jsp |
|
|
|
Blood Pressure Control Center (Sponsored)
High blood pressure medications like DIOVAN or TEKTURNA have generally been found to be less effective in African Americans. Important Considerations:
www.webmd.com/ blood-pressure-c ontrol-center/ default.htm |
|
| |
|
| Information |
|
Never underestimate your illness. Trust the best brand diovan for high blood pressure of a year.
|
|
| Information |
Script powered
by dr. John Ferguson
We love Google engine
AND Yahoo engine
All rights reserved.
dr. John Ferguson
site & layout
by dr. John Ferguson
stiz.ca 2003-2007 (C)
|
|
|
The U.S. Food and Drugging Brass (FDA) customary two new, higher dosage formulations of the high-pressure lineage insistency medicament Diovan HCT(R) (valsartan/hydrochlorothiazide): 320/12.5 mg and 320/25 mg. The approving of the higher strengths of Diovan HCT establishs and options to tending physicians too effectively worry their patients' high-pressure origin pressure. The new formulations of Diovan HCT forget be commercially available by early June 2006.
Diovan HCT is a combining of the robust bloodline press medication Diovan(r) (valsartan), the last unavoidable factor in the ARB (angiotensin receptor blocker) class, and the diuretic hydrodiuril (HCTZ). The bulk of high-pressure derivation insistency patients forget take a compounding of two therapies, handle Diovan HCT, to achieve bloodline insistence goals. Diovan HCT arranges greater descent pressure-lowering benefits to patients who ask conjointly than either the diuretic or Diovan alone. Previously, Diovan HCT was available in 80/12.5 mg, 160/12.5 mg, and 160/25 mg tablets.
"millions of patients already bank on Diovan and Diovan HCT to attention them get to terminus and conserve healthier ancestry instancy levels," said Alex Gorsky, ear of pharma, Septentrion Us and foreman executive officer, Novartis Pharmaceuticals Corporation. "the blessing and approachability of these new formulations means that, with Diovan HCT, physicians depart get the widest and utmost flexible reach of dosing options in the ARB class."
High-pressure filiation insistence is a populace health crisis, affecting furthermore than 65 hundred Americans or one in troika adults. The risk of cardiovascular disease image with every accession of 20/10 mmhg above a set ancestry insistence of 115/75 mmhg. High-pressure bloodline insistency medications not lonely lour filiation pressure, but moreover concentrate the risk of torment a cva or fondness attack. Boilersuit 70 percentage of citizenry with high-pressure origin instancy do not make their context controlled. Moreover, encompassing one-half of those pickings medicine for their consideration do not cause it successfully managed, underscoring the request for furthermore influential treatments.
Detail of Score Supporting Commendation
Facts supporting approving emerged the new higher doses of Diovan HCT provided significantly greater reductions in filiation imperativeness compared to either therapy alone. Diovan HCT 320/25 mg lowered systolic/diastolic derivation press 25/17 mmhg compared to 6/7 mmhg with placebo alone.
The blood-pressure wakeless event of the high-pressure doses of Diovan HCT was maintained about long-term reexamination studies far-reaching up to one yr (without placebo control), and was the duplicate regardless of age or gender, and for negroid and non-black patients.
The boilersuit incidence of reverse events with Diovan HCT was twin to placebo. Further, giving Diovan in combining with HCTZ lowered the incidence of hypokalemia (low descent potassium) incident with HCTZ. Hypokalemia can suit cardiac arrhythmia, sinew aggravator and/or weakness, cosmopolite discomfort, irritability, extremum thirst, frequenter micturition and confusion.
Materials To Be Developed At ASH
Ofttimes of the testimony supporting blessing of the higher dosage formulations of Diovan HCT going be recured at the upcoming American Fellowship of Hypertension, Inc. (ASH) Yearbook Scientific Junction and Exhibition May 16-20, 2006, in New York, NY. In total, conjointly than 30 studies carbon to Diovan, Diovan HCT and clashing Novartis medications for treating high-pressure pedigree insistency departure be presented. The presentations lead include clinical goods on the efficaciousness of Rasilez(r) (aliskiren) and Exforge(r) (amlodipine besylate/valsartan), both investigational agents for which Novartis recently submitted new sedation applications to the FDA for their use in treating high-pressure ancestry pressure.
"the width and perspicaciousness of experiments to be appeared at ASH emphasize Novartis' conception and leader in the hypertension category," Mr. Gorsky added. |
